We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHUBA
2651
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
$209K ﹤0.01%
13,918
+678
+5% +$10.2K
STS
2652
DELISTED
Supreme Industries Inc Class A
STS
$209K ﹤0.01%
13,309
-88
-0.7% -$1.32K
SQBG
2653
DELISTED
Sequential Brands Group, Inc.
SQBG
$208K ﹤0.01%
1,112
-23
-2% -$5.58K
MODN
2654
DELISTED
MODEL N, INC.
MODN
$207K ﹤0.01%
23,358
+1,663
+8% +$15.5K
MBTF
2655
DELISTED
MBT Financial Corporation
MBTF
$207K ﹤0.01%
18,247
-4,139
-18% -$40.3K
LAYN
2656
DELISTED
Layne Christensen Co
LAYN
$207K ﹤0.01%
19,021
-4,043
-18% -$39.1K
HCCI
2657
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$206K ﹤0.01%
13,099
-913
-7% -$13.2K
STML
2658
DELISTED
Stemline Therapeutics, Inc.
STML
$206K ﹤0.01%
19,231
-5,876
-23% -$71.1K
INST
2659
DELISTED
Instructure, Inc.
INST
$206K ﹤0.01%
10,520
+2,053
+24% +$44K
ESPR
2660
DELISTED
Esperion Therapeutics
ESPR
$205K ﹤0.01%
16,334
-1,002
-6% -$11.9K
LCTX icon
2661
Lineage Cell Therapeutics
LCTX
$269M
$205K ﹤0.01%
64,885
+6,717
+12% +$20.6K
NRC icon
2662
NRC Health Common Stock
NRC
$432M
$205K ﹤0.01%
10,772
+455
+4% +$7.51K
MEET
2663
DELISTED
The Meet Group, Inc. Common Stock
MEET
$205K ﹤0.01%
41,505
-1,049
-2% -$5.42K
TRR
2664
DELISTED
Trc Companies
TRR
$204K ﹤0.01%
19,250
-214
-1% -$1.99K
NHTC icon
2665
Natural Health Trends
NHTC
$14.7M
$203K ﹤0.01%
8,163
+570
+8% +$14.3K
EGIO
2666
DELISTED
Edgio, Inc. Common Stock
EGIO
$203K ﹤0.01%
2,016
+103
+5% +$8.73K
FBIZ icon
2667
First Business Financial Services
FBIZ
$587M
$202K ﹤0.01%
8,499
-588
-6% -$13.1K
CMRX
2668
DELISTED
Chimerix, Inc.
CMRX
$202K ﹤0.01%
43,892
-1,675
-4% -$7.91K
CSLT
2669
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$202K ﹤0.01%
40,843
+8,756
+27% +$39.7K
HIFS icon
2670
Hingham Institution for Saving
HIFS
$627M
$201K ﹤0.01%
+1,019
New +$164K
XBKS
2671
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$201K ﹤0.01%
7,111
+1,016
+17% +$25.3K
PDSB icon
2672
PDS Biotechnology
PDSB
$38.4M
$200K ﹤0.01%
800
+52
+7% +$11.8K
NVTA
2673
DELISTED
Invitae Corporation
NVTA
$200K ﹤0.01%
25,136
+6,127
+32% +$45.8K
GORO icon
2674
Goldgroup Mining Inc.
GORO
$157M
$199K ﹤0.01%
45,690
-2,232
-5% -$11K
QNST icon
2675
QuinStreet
QNST
$890M
$199K ﹤0.01%
53,042
-15,536
-23% -$50.4K

Similar funds

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.